Experimental & Applied Sciences

From Wikipedia, the free encyclopedia

Experimental & Applied Sciences Inc (EAS)

Type	Private
Founded	Monterey County, California, USA (1992)
Headquarters	Golden, Colorado, USA
Key people	Anthony Almada and Ed Byrd (Co-founders); Bill Phillips (former CEO)
Industry	Nutritional supplements
Products	Creatine monohydrate, dietary and sports supplements
Website	eas.com

Experimental & Applied Sciences, Inc (better known as "EAS") is the world's largest distributor of performance based nutritional supplements with approximately 300 staff, annual sales exceeding $300 million dollars and offices/distributors in 54 countries.

EAS was founded in Pacific Grove, Monterey County, California in 1992 by a biochemist named Anthony Almada, and a businessman named Ed Byrd . After discovering the possible benefits for athletes of creatine monohydrate supplementation, in December of 1992 they acquired a kilogram of creatine and began trials on themselves.

EAS's flagship product Phosphagen

In 1993 Almada and Byrd released the first commercially available^{[citation needed]} creatine supplement designed specifically for strength and muscle enhancement under the EAS brand name Phosphagen. That same year their discovery caught the eye of Bill Phillips, publisher of Muscle Media 2000 (usually referred to as "MM2K"), and he began to write about its benefits in the "Natural Supplement Review" and his subscriber based newsletters. Phillips was so impressed that in 1994 he purchased EAS from Almada and Byrd.

Phillips' loyal subscriber base was the perfect platform to which to tout his new acquisition, and it was from here that EAS growth really began. He promoted the company's products through heavy editorial-style advertisements in MM2K, and led by flagship products like Myoplex (which is a copy of MET-Rx, a product Phillips sold under a previous venture), Phosphagen and HMB this would eventually put EAS at the forefront of the nutritional supplement industry.

In 1999, Phillips sold his majority interest in EAS (though he remained on the Board of Directors for a number of years afterward) to a private equity firm and concentrated on his writing and on promotion of his books through his publishing company, High Point Media. In 2004, he completely sold his remaining interest and is no longer involved with EAS.

In 2005 EAS was purchased by Abbott Laboratories and now exists as a solely owned division of Abbott.